Lecture 50 - Pharmacotherapy of Migraines Flashcards

1
Q

Migraine types

A

migraine without aura (common)
migraine with aura (classic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Migraine without aura (common) - diagnostic criteria

A

◦ At least five attacks
◦ Headache lasting 4 – 72 hours
◦ Unilateral location, pulsating quality, moderate/severe pain, aggravation
by routine activity
◦ Nausea and/or vomiting,
photophobia, phonophobia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Migraine with aura (classic)

A

◦ At least two attacks
◦ At least one fully reversible aura
◦ No aura lasting more than 60 minutes
◦ Headache follows aura within 60 min
◦ Aura symptoms: visual, sensory, speech/language, motor, brainstem, retinal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Migraine headache phases

A

1: prodrome
2: aura
3: migraine headache
4: postdromal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Prodrome

A
  • Hours or days
    before onset of
    headache
  • May experience
    euphoria, depression,
    irritability, food
    craving, constipation, neck
    stiffness, yawning
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Aura

A

15-30% of patients
* Commonly visual, may be sensory, verbal, or motor
* Before or during migraine, lasts less than 60 minutes
* Photopsia (flash of
light or floater in
eye), scotoma (blind spot), zigzag lines, numbness/tingling
in arms, legs, face

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Migraine headache

A
  • Dull ache that intensifies
  • Unilateral and throbbing
  • Phonophobia, photophobia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Postdromal

A
  • May last several days after headache has ended
  • Tiredness, head pain, GI distress, mood changes, weakness, cognitive difficulties
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Migraine triggers

A

Medication Overuse Headache
* Associated with analgesics, ergots, triptans – rebound headaches from medication overuse more than two times per headache or two times per week chronically
* Can be managed by gradual reduction of medication use limited to no more than 2 doses per headache or two times per week and avoidance of butalbital/opioids – use meds with less withdrawal potential (low-dose NSAID)
Medications: oral contraceptives, hydralazine, nitroglycerin, nifedipine, cocaine
Diet: chocolate, oranges, tomatoes, onions, aged cheese, processed meats, cultured dairy, alcohol (specifically red wine and champagne), caffeine
Additives/preservatives: aspartame and monosodium glutamate
Environment: altitude/weather changes, perfume, tobacco smoke, loud noises, flickering lights Too little or too much sleep, skipping meals, stress, hormone changes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Avoid _____ in treatment

A

analgesic overuse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Abortive treatment

A

◦ Education to avoid medication overuse
◦ Mild-moderate: NSAIDs, acetaminophen
◦ Moderate-severe: triptans/ergots

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Preventive treatment

A

◦ Four or more attacks/month with disability at least 3 days/month

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Abortive treatment guidelines

A

first line: triptans, NSAIDs
second line: NSAIDs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Prevention treatment guidelines

A

first line: monotherapy: valproate, topiramate, metoprolol, propranolol, frovatriptan
second line: monotherapy: amitriptyline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Non-pharmacolgical therapy

A

biofeedback and relaxation therapy
cognitive behavioral therapy
diet
sleep
transcutaneous electrical nerve stimulatiion device
exercise, massage, acupuncture, thermal biofeedback, heat/cold applications, headache diary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Overview of triptans for abortive treatment: contraindications

A

Contraindications: recent use (within 24 hours) of an ergot or other triptan, MAO-A inhibitor use in the last 2 weeks (frovatriptan, rizatriptan), ischemic heart disease, angina, history of stroke or TIA or hemiplegic/basilar migraine, arrhythmias, peripheral vascular disease, uncontrolled hypertension, ischemic bowel disease, severe hepatic impairment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Overview of triptans for abortive treatment: warnings/precautions

A

Warnings/precautions: MI, pain/pressure/tightness in chest/throat/neck/jaw, CVA, HTN, GI ischemic reactions or peripheral vasospasm, medication overuse headache, serotonin syndrome, sulfa allergy (almotriptan), corneal opacities (almotriptan), seizures (use with caution)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Overview of triptans for abortive treatment: SEs

A

*Oral – tingling, dizziness, drowsiness, fatigue, chest tightness/pressure, flushing

19
Q

Overview of triptans for abortive treatment: drug interactions

A

*SSRIs/SNRIs – theoretically, the use of a triptan with SSRI/SNRI can increase the risk of serotonin syndrome. This drug interaction is extremely rare and may not be due to the triptans.
*Avoid strong 3A4 inhibitors with eletriptan

20
Q

Ergot alkaloids in abortive treatment: warnings/precautions

A

Boxed warning for serious/life-
threatening peripheral ischemia; warnings for cardiac valvular fibrosis, vasospasms or
vasoconstriction, cerebrovascular events, ergotism (overdose of
ergot-containing medication –
cramps, spasms, dry gangrene from vasoconstriction)

21
Q

Ergot alkaloids in abortive treatment: SEs

A

retroperitoneal, pleuropulmonary, and valvular fibrosis; ergotism, vasoconstrictive complications (ischemia, cyanosis, cold in extremities, gangrene, numbness, weakness, N/V)

22
Q

Ergot alkaloids in abortive treatment: drug interactions

A

3A4 inhibitors – ergot toxicity can result

23
Q

Calcitonin Gene- Related Peptide (CGRP) Receptor Antagonists Abortive Treatment: contraindications

A

contraindicated with strong 3A4 inhibitors

24
Q

Calcitonin Gene- Related Peptide (CGRP) Receptor Antagonists Abortive Treatment: drug interactions

A

moderate/strong 3A4 inducers and inhibitors, p-glycoprotein inhibitors

25
Q

Lasmiditan abortive therapy: warnings/precautions

A

Warnings/precautions:
medication overuse headaches, sedation, dizziness, serotonin syndrome, driving impairment (avoid for at least 8 hours after dose)

26
Q

Lasmiditan abortive therapy: SEs

A

Side effects:
dizziness, fatigue, paresthesia, sedation

27
Q

Lasmiditan abortive therapy: drug interactions

A

use with caution with other CNS depressants and serotonergic medications; avoid use with p-gp or BCRP substrates, other medications that can decrease heart rate

28
Q

Lasmiditan abortive therapy: monitoring

A

LFTs, blood pressure, heart rate (especially in patients with cardiovascular disease)

29
Q

Other abortive therapies

A

Butorphanol nasal spray as a rescue medication

30
Q

Preventive drug therapy: beta blockers

A
  • FDA-approved
    *Propranolol 80 – 240 mg/day *Metoprolol 100 – 200 mg/day
    *Contraindicated in asthma and Raynaud’s syndrome
31
Q

Preventive drug therapy: tricyclic antidepressants

A

*Not FDA-approved
*Amitriptyline 25 – 150 mg/day (mixed migraine/tension-type)

32
Q

Preventive – CGRP Antagonists: SEs

A

*Atogepant: nausea, constipation, fatigue
*Rimegepant: nausea, rash, dyspnea

33
Q

Preventive drug therapy: antiseizure drugs

A

valproate, topiramate (FDA- approved)
*Valproate – 500 – 1500 mg/day, topiramate – 50 – 100 mg/day
*Not recommended in people of child-bearing age unless using contraception

34
Q

Preventive therapy: miscellaneous and natural products

A

butterbur/petasites 150mg/day

35
Q

Migraine Therapy in Pregnancy: dihydroergotamine/ergotamine

A

contraindicated in pregnancy,
use of contraception is
recommended

36
Q

Migraine Therapy in Pregnancy: triptans

A

recommended for use only if the benefit outweighs the risk to the fetus

37
Q

Migraine Therapy in Pregnancy: valproate

A

contraindicated in pregnancy when used for the treatment of migraines, contraception is recommended

38
Q

Migraine Therapy in Pregnancy: topiramate

A

may cause fetal harm if used during pregnancy (cleft lip/palate and reduced birth weight); if used during pregnancy, monitor for the development of metabolic acidosis during and after pregnancy

39
Q

Migraine therapy in children: almotriptan

A

12 years of age and older

40
Q

Migraine therapy in children: rizatriptan

A

6 years of age and older

41
Q

Migraine therapy in children: zolmitriptan nasal spray

A

12 years of age and older

42
Q

Migraine therapy in children: sumatriptan nasal spray

A

not FDA-approved in children

43
Q

Migraine therapy in children: sumatriptan/naproxen

A

12 years and older

44
Q

Migraine therapy in children: topiramate

A

12 years of age and older